We are focused on discovery and early development of therapeutics targeting Cytochromes P450 (CYPs) – a superfamily of proteins, widely distributed in all kingdoms of life and involved in crucial biochemical pathways.
In certain pathological conditions a therapeutic effect can be achieved by modification of relevant CYPs’ activity. Based on scienific research we have developed a proprietary technological platform – CRYSTA – it integrates a number of special in vitro techniques of rational drug discovery to reach desired target selectivity, efficacy and safety profile, derisking compounds at early steps.
Crystallography remains one of the most multidisciplinary sciences that links together frontier areas of research and has, directly or indirectly, produced the largest number of Nobel Laureates throughout history.
Protein crystallization is a main part of our technological platform giving a most effective tool for compound optimization .